King's College London

Research portal

Chondroitinase ABC promotes functional recovery after spinal cord injury

Research output: Contribution to journalArticle

E J Bradbury, L D F Moon, R J Popat, V R King, G S Bennett, P N Patel, J W Fawcett, S B McMahon

Original languageEnglish
Pages (from-to)636 - 640
Number of pages5
JournalNATURE
Volume416
Issue number6881
DOIs
Publication statusPublished - 11 Apr 2002

King's Authors

Abstract

The inability of axons to regenerate after a spinal cord injury in the adult mammalian central nervous system (CNS) can lead to permanent paralysis. At sites of CNS injury, a glial scar develops, containing extracellular matrix molecules including chondroitin sulphate proteoglycans (CSPGs)(1,2). CSPGs are inhibitory to axon growth in vitro(3-5), and regenerating axons stop at CSPG-rich regions in vivo(6). Removing CSPG glycosaminoglycan (GAG) chains attenuates CSPG inhibitory activity(7-10). To test the functional effects of degrading chondroitin sulphate (CS)-GAG after spinal cord injury, we delivered chondroitinase ABC (ChABC) to the lesioned dorsal columns of adult rats. We show that intrathecal treatment with ChABC degraded CS-GAG at the injury site, upregulated a regeneration-associated protein in injured neurons, and promoted regeneration of both ascending sensory projections and descending corticospinal tract axons. ChABC treatment also restored post-synaptic activity below the lesion after electrical stimulation of corticospinal neurons, and promoted functional recovery of locomotor and proprioceptive behaviours. Our results demonstrate that CSPGs are important inhibitory molecules in vivo and suggest that their manipulation will be useful for treatment of human spinal injuries.

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454